PDHX acetylation facilitates tumor progression by disrupting PDC assembly and activating lactylation-mediated gene expression
Protein & Cell · 04.01.2025 · 16 (1) · 49-63
DOI: 10.1093/procel/pwae052 ↗Kurz gefasst
Fachartikel in der Zeitschrift Protein & Cell, online erschienen am 23.09.2024. Verfasst von Zetan Jiang und 12 weiteren Autor:innen. Beteiligte Einrichtung: Department of General Surgery, Anhui Provincial Hospital, The First Affiliated Hospital of USTC, Division of Life Science and Medicine, University of…. Hauptthemen laut MEDLINE: Carcinoma, Hepatocellular, Liver Neoplasms. Die Arbeit wurde bisher 63-mal zitiert (Crossref) und nennt 60 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY 4.0). Gefördert von: National Natural Science Foundation of China, National Key R&D Program of China, Chinese Academy of Sciences.
Abstract (Originalsprache)
Deactivation of the mitochondrial pyruvate dehydrogenase complex (PDC) is important for the metabolic switching of cancer cell from oxidative phosphorylation to aerobic glycolysis. Studies examining PDC activity regulation have mainly focused on the phosphorylation of pyruvate dehydrogenase (E1), leaving other post-translational modifications largely unexplored. Here, we demonstrate that the acetylation of Lys 488 of pyruvate dehydrogenase complex component X (PDHX) commonly occurs in hepatocellular carcinoma, disrupting PDC assembly and contributing to lactate-driven epigenetic control of gene expression. PDHX, an E3-binding protein in the PDC, is acetylated by the p300 at Lys 488, impeding the interaction between PDHX and dihydrolipoyl transacetylase (E2), thereby disrupting PDC assembly to inhibit its activation. PDC disruption results in the conversion of most glucose to lactate, contributing to the aerobic glycolysis and H3K56 lactylation-mediated gene expression, facilitating tumor progression. These findings highlight a previously unrecognized role of PDHX acetylation in regulating PDC assembly and activity, linking PDHX Lys 488 acetylation and histone lactylation during hepatocellular carcinoma progression and providing a potential biomarker and therapeutic target for further development.
Schlagwörter
MeSH-Schlagwörter (MEDLINE)
Stichwörter der Autor:innen
Substanzen
Autor:innen und Institutionen
- Department of General Surgery, Anhui Provincial Hospital, The First Affiliated Hospital of USTC, Division of Life Science and Medicine, University of Science and Technology of China, Hefei 230027, China.
- The Chinese Academy of Sciences Key Laboratory of Innate Immunity and Chronic Disease, School of Basic Medical Sciences, Division of Life Science and Medicine, University of Science and Technology of China, Hefei 230027…
- Insitute of Health and Medicine, Hefei Comprehensive National Science Center, Hefei 230601, China.
- Medical Research Institute, Guangdong Provincial People's Hospital, Guangdong Academy of Medical Sciences, Southern Medical University, Guangzhou 510080, China.
Förderung
- National Natural Science Foundation of China
- National Key R&D Program of China
- Chinese Academy of Sciences
- Global Select Project
- Institute of Health and Medicine, Hefei Comprehensive National Science Center and the Fundamental Research Funds for the Central Universities
Zitieren
APA
Jiang, Z., Xiong, N., Yan, R., Li, S. T., Liu, H., Mao, Q., Sun, Y., Shen, S., Ye, L., Gao, P., Zhang, P., Jia, W., & Zhang, H. (2025). PDHX acetylation facilitates tumor progression by disrupting PDC assembly and activating lactylation-mediated gene expression. Protein & Cell, 16(1), 49-63. https://doi.org/10.1093/procel/pwae052
Vancouver
Jiang Z, Xiong N, Yan R, Li ST, Liu H, Mao Q, et al. PDHX acetylation facilitates tumor progression by disrupting PDC assembly and activating lactylation-mediated gene expression. Protein & Cell. 2025;16(1):49-63. doi:10.1093/procel/pwae052
BibTeX
@article{Jiang2025,
author = {Jiang, Zetan and Xiong, Nanchi and Yan, Ronghui and Li, Shi-Ting and Liu, Haiying and Mao, Qiankun and Sun, Yuchen and Shen, Shengqi and Ye, Ling and Gao, Ping and Zhang, Pinggen and Jia, Weidong and Zhang, Huafeng},
title = {PDHX acetylation facilitates tumor progression by disrupting PDC assembly and activating lactylation-mediated gene expression},
journal = {Protein & Cell},
year = {2025},
volume = {16},
number = {1},
pages = {49--63},
doi = {10.1093/procel/pwae052}
}
EUVIMED